TCL Archive NCI Initiative: Start With Mechanism, Then answer The Many Questions, Klauser Says to Advisors November 29, 1996
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises July 21, 1989